Perspectives on Capital Markets
71 total results. Page 1 of 3.
ArentFox Schiff represented NextPlat Corp (NASDAQ:NXPL)(NASDAQ:NXPLW) in its $6 million private placement of common stock.
ArentFox Schiff is representing TruGolf, Inc., a leading golf simulator manufacturer and distributor, in its announced merger with Deep Medicine Acquisition Corp. (NASDAQ: DMAQ), a publicly traded special purpose acquisition company.
ArentFox Schiff represented The Benchmark Company, LLC as sole bookrunning manager in ICZOOM Group Inc.’s initial public offering.
The Inflation Reduction Act of 2022, which was signed into law on August 16, 2022, enacted a new 1% excise tax on certain repurchases of the stock of publicly traded corporations, codified in Section 4501 of the Internal Revenue Code of 1986 (the Excise Tax).
ArentFox Schiff represented NextPlat Corp in its $8 million private placement of common stock and warrants.
ArentFox Schiff is hosting and Mike Andresino is speaking at the NASPP Boston Chapter’s seminar on November 29, 2022.
ArentFox Schiff represented NorthView Acquisition Corp., a publicly traded special purpose acquisition company, in its merger with Profusa, Inc., a digital health company.
We represented NextPlat Corp., a global e-commerce platform company, in its strategic investments in Progressive Care Inc., a personalized healthcare services and technology company.
ArentFox Schiff represented a subsidiary of an investor-owned public utility in its $400 million underwritten public offering of 30-year General and Refunding Mortgage Notes.
We represented Boustead Securities, LLC as the sole underwriter in Know Labs, Inc.’s $8.28 million public offering of common stock.
ArentFox Schiff is pleased to announce that the firm and two partners have been shortlisted for the annual LMG Life Sciences Americas Awards.
We represented Global Blockchain Acquisition Corp. on its initial public offering of 15,000,000 units at a price to the public of $10.00 per unit. The offering closed May 12, 2022.
We represented Maxim Group LLC, as managing underwriter of a $185 million initial public offering for A SPAC II Acquisition Corp. The offering consists of 18,500,000 units at a price of $10.00 per unit. The offering closed on May 5, 2022.
ArentFox Schiff LLP assisted with ClimateRock’s $75 million initial public offering.
ArentFox Schiff LLP represented The Benchmark Company, LLC as underwriter in Tenon Medical, Inc.’s initial public offering. The $16 million IPO closed on April 29, 2022.
Schiff Hardin LLP assisted Smart for Life, Inc. in its $14.4 million initial public offering. Smart for Life is a leading developer, marketer, and manufacturer of nutritional and related products.
Schiff Hardin LLP advised I-Bankers Securities, Inc., the managing underwriter of AXIOS Sustainable Growth Acquisition Corporation in AXIOS’ initial public offering of 15,000,000 units, which will result in gross proceeds to AXIOS of $150 million.
Schiff Hardin LLP advised Orbsat Corp, a global e-commerce provider of IoT and connectivity solutions through next-generation satellite technology, on its public offering.
Schiff Hardin LLP advised NorthView Acquisition Group in its initial public offering of 18,975,000 units resulting in total gross proceeds of $189,750,000.
Schiff Hardin LLP served underwriters’ counsel for Sidus Space, Inc.’s $15 million initial public offering.
Schiff Hardin LLP served as counsel to the underwriter for Financial Strategies Acquisition Corp.’s initial public offering of 10,005,000 units, resulting in total gross proceeds of $100 million.
Schiff Hardin LLP served as counsel to the underwriter for Aditxt, Inc.’s $17.4 million public offering of common stock and warrants, which closed Dec. 6, 2021.
Schiff Hardin LLP served as underwriter’s counsel for Canna-Global Acquisition Corp.’s initial public offering of $200 million, which closed on Dec. 2, 2021.
Schiff Hardin LLP advised the placement agents for Biofrontera Inc.’s $15 million private placement with a single institutional investor for the purchase of 2,857,143 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to an aggregate of 2,857,143 shares of common stock.
Schiff Hardin LLP served as underwriter’s counsel for Deep Medicine Acquisition Corp.’s upsized initial public offering raising gross proceeds of $126.5 million.